Tablet sales continued their upward trajectory in the third quarter of 2024, growing 5% year on year to 7.7 million units, ...
On 6 December, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that the first prescriptions for the innovative drug Lumeblue ® (Methylthioninium Chloride ...